Meeting of the Tick-Borne Disease Working Group, 55553 [2018-24260]

Download as PDF Federal Register / Vol. 83, No. 215 / Tuesday, November 6, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Tick-Borne Disease Working Group Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS) announces the eighth meeting of the Tick-Borne Disease Working Group (Working Group) on December 3, 2018, from 1:00 p.m. to 4:00 p.m., Eastern Time. The eighth meeting will be an online meeting held via webcast. The Working Group will review the work of the public comments subcommittee, discuss the release of the 2018 Report to Congress, recognize the subcommittee members for their contributions to the 2018 Report, and address the next steps and transition to a new Working Group for the 2020 Report to Congress. DATES: The meeting will be held on December 3, 2018, from 1:00 p.m. to 4:00 p.m., Eastern Time. ADDRESSES: This will be an online meeting that is held via webcast. Members of the public may attend the meeting via webcast. Instructions for attending the meeting via webcast will be posted one week prior to the meeting at: https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ index.html. SUMMARY: khammond on DSK30JT082PROD with NOTICES FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services; via email at tickbornedisease@ hhs.gov or by phone at 202–795–7697. SUPPLEMENTARY INFORMATION: The Working Group invites public comment on issues related to the Working Group’s charge. It may be provided via webcast at the meeting or in writing. Persons who wish to provide public comment via webcast should review directions at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/ index.html before submitting a request to do so via email at tickbornedisease@ hhs.gov. Requests to provide webcast comments are due on or before November 26, 2018, and will be limited to three minutes each to accommodate as many speakers as possible. If more requests are received than can be accommodated, speakers will be randomly selected. The nature of the comments will not be considered in VerDate Sep<11>2014 17:05 Nov 05, 2018 Jkt 247001 making this selection. Public comments may also be provided in writing. Individuals who would like to provide written comments should review directions at https://www.hhs.gov/ash/ advisory-committees/tickbornedisease/ meetings/index.html before sending their comments to tickbornedisease@ hhs.gov on or before November 26, 2018. During the meeting, the Working Group will review the work of the public comments subcommittee, discuss the release of the 2018 Report to Congress, recognize the subcommittee members for their contributions to the 2018 Report, and address the next steps and transition to a new Working Group for the 2020 Report to Congress. Background and Authority: The TickBorne Disease Working Group was established on August 10, 2017, in accordance with section 2062 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review all HHS efforts related to tickborne diseases to help ensure interagency coordination and minimize overlap, examine research priorities, and identify and address unmet needs. In addition, the Working Group will report to the Secretary and Congress on their findings and any recommendations for the federal response to tick-borne disease prevention, treatment and research, and addressing gaps in those areas. Dated: October 25, 2018. James J. Berger, Senior Advisor for Blood and Tissue Policy, Designated Federal Officer, Tick-Borne Disease Working Group. [FR Doc. 2018–24260 Filed 11–5–18; 8:45 am] BILLING CODE 4150–28–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of Inspector General [OIG–1810–N] Statement of Organization, Functions, and Delegations of Authority Office of Inspector General (OIG), HHS. ACTION: Notice. AGENCY: This notice replaces all language in Part Q (Office of the Secretary) of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (HHS or the Department), Office of Inspector General (OIG) (81 FR 13807, as published March 15, 2016). SUMMARY: PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 55553 The Statement of Organization, Functions, and Delegations of Authority conforms to and carries out the statutory requirements for operating OIG. The organizational changes reflected in this notice are primarily to realign the functions within OIG to better reflect the current work environment and priorities and to more clearly delineate responsibilities for the various activities within OIG’s offices. OIG was established by law as an independent and objective oversight unit of the Department to carry out the mission of preventing fraud and abuse and promoting economy, efficiency, and effectiveness of HHS programs and operations. In furtherance of this mission, the organization: • Conducts and supervises audits, investigations, evaluations, and inspections relating to HHS programs and operations; • identifies systemic weaknesses giving rise to opportunities for fraud and abuse in HHS programs and operations and makes recommendations to prevent their recurrence; • leads and coordinates activities to prevent and detect fraud and abuse in HHS programs and operations; • detects wrongdoers and abusers of HHS programs and beneficiaries so appropriate remedies may be brought to bear, including imposing administrative sanctions against providers of health care under Medicare and Medicaid who commit certain prohibited acts; and • keeps the Secretary of Health and Human Services and Congress fully and currently informed about problems and deficiencies in the administration of HHS programs and operations and about the need for and progress of corrective action. In addition, OIG works with the Department of Justice (DOJ), on behalf of the Secretary, to operate the Health Care Fraud and Abuse Control Program. In accordance with authority enacted in its annual appropriations, OIG also provides protection services to the Secretary and conducts criminal investigations of violations of Federal child support provisions. In support of its mission, OIG carries out and maintains an internal quality assurance system and a peer-review system with other Offices of Inspector General, including periodic quality assessment studies and quality control reviews, to provide reasonable assurance that applicable laws, regulations, policies, procedures, standards, and other requirements are followed, are effective, and are functioning as intended in OIG operations. E:\FR\FM\06NON1.SGM 06NON1

Agencies

[Federal Register Volume 83, Number 215 (Tuesday, November 6, 2018)]
[Notices]
[Page 55553]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-24260]



[[Page 55553]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) announces 
the eighth meeting of the Tick-Borne Disease Working Group (Working 
Group) on December 3, 2018, from 1:00 p.m. to 4:00 p.m., Eastern Time. 
The eighth meeting will be an online meeting held via webcast. The 
Working Group will review the work of the public comments subcommittee, 
discuss the release of the 2018 Report to Congress, recognize the 
subcommittee members for their contributions to the 2018 Report, and 
address the next steps and transition to a new Working Group for the 
2020 Report to Congress.

DATES: The meeting will be held on December 3, 2018, from 1:00 p.m. to 
4:00 p.m., Eastern Time.

ADDRESSES: This will be an online meeting that is held via webcast. 
Members of the public may attend the meeting via webcast. Instructions 
for attending the meeting via webcast will be posted one week prior to 
the meeting at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html.

FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and 
Infectious Disease Policy, Office of the Assistant Secretary for 
Health, Department of Health and Human Services; via email at 
[email protected] or by phone at 202-795-7697.

SUPPLEMENTARY INFORMATION: The Working Group invites public comment on 
issues related to the Working Group's charge. It may be provided via 
webcast at the meeting or in writing. Persons who wish to provide 
public comment via webcast should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html before submitting a request to do so via email at 
[email protected]. Requests to provide webcast comments are due 
on or before November 26, 2018, and will be limited to three minutes 
each to accommodate as many speakers as possible. If more requests are 
received than can be accommodated, speakers will be randomly selected. 
The nature of the comments will not be considered in making this 
selection. Public comments may also be provided in writing. Individuals 
who would like to provide written comments should review directions at 
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html before sending their comments to [email protected] on 
or before November 26, 2018. During the meeting, the Working Group will 
review the work of the public comments subcommittee, discuss the 
release of the 2018 Report to Congress, recognize the subcommittee 
members for their contributions to the 2018 Report, and address the 
next steps and transition to a new Working Group for the 2020 Report to 
Congress.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review all HHS 
efforts related to tick-borne diseases to help ensure interagency 
coordination and minimize overlap, examine research priorities, and 
identify and address unmet needs. In addition, the Working Group will 
report to the Secretary and Congress on their findings and any 
recommendations for the federal response to tick-borne disease 
prevention, treatment and research, and addressing gaps in those areas.

    Dated: October 25, 2018.
James J. Berger,
Senior Advisor for Blood and Tissue Policy, Designated Federal Officer, 
Tick-Borne Disease Working Group.
[FR Doc. 2018-24260 Filed 11-5-18; 8:45 am]
 BILLING CODE 4150-28-P